FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891284330> ?p ?o ?g. }

• W2891284330 abstract "Glioblastomas (GBMs), the most common and most lethal of the primary brain tumors, are characterized by marked intra-tumor heterogeneity. Several studies have suggested that within these tumors a restricted population of chemoresistant glioma cells is responsible for recurrence. However, the gene expression patterns underlying chemoresistance are largely unknown. Numerous efforts have been made to block IGF-1R signaling pathway in GBM. However, those therapies have been repeatedly unsuccessful. This failure may not only be due to the complexity of IGF receptor signaling, but also due to complex cell-cell interactions in the tumor mass. We hypothesized that differential expression of proteins in the insulin-like growth factor (IGF) system underlie cell-specific differences in the resistance to temozolomide (TMZ) within GBM tumors.Expression of IGF-1R was analyzed in cell lines, patient-derived xenograft cell lines and human biopsies by cell surface proteomics, flow cytometry, immunofluorescence and quantitative real time polymerase chain reaction (qRT-PCR). Using gain-of-function and loss-of-function strategies, we dissected the molecular mechanism responsible for IGF-binding protein 6 (IGFBP6) tumor suppressor functions both in in vitro and in vivo. Site direct mutagenesis was used to study IGFBP6-IGF2 interactions.We determined that in human glioma tissue, glioma cell lines, and patient-derived xenograft cell lines, treatment with TMZ enhances the expression of IGF1 receptor (IGF-1R) and IGF2 and decreases the expression of IGFBP6, which sequesters IGF2. Using chemoresistant and chemosensitive wild-type and transgenic glioma cells, we further found that a paracrine mechanism driven by IGFBP6 secreted from TMZ-sensitive cells abrogates the proliferation of IGF-1R-expressing TMZ-resistant cells in vitro and in vivo. In mice bearing intracranial human glioma xenografts, overexpression of IGFBP6 in TMZ-resistant cells increased survival. Finally, elevated expression of IGF-1R and IGF2 in gliomas associated with poor patient survival and tumor expression levels of IGFBP6 directly correlated with overall survival time in patients with GBM.Our findings support the view that proliferation of chemoresistant tumor cells is controlled within the tumor mass by IGFBP6-producing tumor cells; however, TMZ treatment eliminates this population and enriches the TMZ-resistant cell populationleading to accelerated growth of the entire tumor mass." @default.
• W2891284330 created "2018-09-27" @default.
• W2891284330 creator A5015247761 @default.
• W2891284330 creator A5022997720 @default.
• W2891284330 creator A5023416974 @default.
• W2891284330 creator A5031831970 @default.
• W2891284330 creator A5034153294 @default.
• W2891284330 creator A5044496405 @default.
• W2891284330 creator A5047734216 @default.
• W2891284330 date "2018-09-19" @default.
• W2891284330 modified "2023-09-30" @default.
• W2891284330 title "IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling" @default.
• W2891284330 cites W1483206320 @default.
• W2891284330 cites W1541324451 @default.
• W2891284330 cites W1542183320 @default.
• W2891284330 cites W1544655463 @default.
• W2891284330 cites W1941265760 @default.
• W2891284330 cites W1976633761 @default.
• W2891284330 cites W1982585367 @default.
• W2891284330 cites W1988339729 @default.
• W2891284330 cites W1991191152 @default.
• W2891284330 cites W1992732876 @default.
• W2891284330 cites W1993812419 @default.
• W2891284330 cites W1996624229 @default.
• W2891284330 cites W2000622771 @default.
• W2891284330 cites W2000647702 @default.
• W2891284330 cites W2000978272 @default.
• W2891284330 cites W2014602200 @default.
• W2891284330 cites W2014877570 @default.
• W2891284330 cites W2016816289 @default.
• W2891284330 cites W2017301682 @default.
• W2891284330 cites W2019629273 @default.
• W2891284330 cites W2022066788 @default.
• W2891284330 cites W2043913297 @default.
• W2891284330 cites W2058911076 @default.
• W2891284330 cites W2059668898 @default.
• W2891284330 cites W2061427138 @default.
• W2891284330 cites W2062866218 @default.
• W2891284330 cites W2064651108 @default.
• W2891284330 cites W2067008256 @default.
• W2891284330 cites W2078761044 @default.
• W2891284330 cites W2092618391 @default.
• W2891284330 cites W2104287659 @default.
• W2891284330 cites W2107963656 @default.
• W2891284330 cites W2110035440 @default.
• W2891284330 cites W2111843196 @default.
• W2891284330 cites W2113942802 @default.
• W2891284330 cites W2130884130 @default.
• W2891284330 cites W2141055671 @default.
• W2891284330 cites W2144678487 @default.
• W2891284330 cites W2148977460 @default.
• W2891284330 cites W2154466664 @default.
• W2891284330 cites W2156333188 @default.
• W2891284330 cites W2167241157 @default.
• W2891284330 cites W2168805837 @default.
• W2891284330 cites W2211132464 @default.
• W2891284330 cites W2258953365 @default.
• W2891284330 cites W2337551962 @default.
• W2891284330 cites W2409607343 @default.
• W2891284330 cites W2413138283 @default.
• W2891284330 cites W2517957586 @default.
• W2891284330 cites W2554863679 @default.
• W2891284330 cites W2769682126 @default.
• W2891284330 cites W2770199474 @default.
• W2891284330 cites W2776757966 @default.
• W2891284330 cites W4212949515 @default.
• W2891284330 doi "https://doi.org/10.1186/s12964-018-0273-7" @default.
• W2891284330 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6148802" @default.
• W2891284330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30231881" @default.
• W2891284330 hasPublicationYear "2018" @default.
• W2891284330 type Work @default.
• W2891284330 sameAs 2891284330 @default.
• W2891284330 citedByCount "17" @default.
• W2891284330 countsByYear W28912843302019 @default.
• W2891284330 countsByYear W28912843302020 @default.
• W2891284330 countsByYear W28912843302021 @default.
• W2891284330 countsByYear W28912843302022 @default.
• W2891284330 countsByYear W28912843302023 @default.
• W2891284330 crossrefType "journal-article" @default.
• W2891284330 hasAuthorship W2891284330A5015247761 @default.
• W2891284330 hasAuthorship W2891284330A5022997720 @default.
• W2891284330 hasAuthorship W2891284330A5023416974 @default.
• W2891284330 hasAuthorship W2891284330A5031831970 @default.
• W2891284330 hasAuthorship W2891284330A5034153294 @default.
• W2891284330 hasAuthorship W2891284330A5044496405 @default.
• W2891284330 hasAuthorship W2891284330A5047734216 @default.
• W2891284330 hasBestOaLocation W28912843301 @default.
• W2891284330 hasConcept C128240485 @default.
• W2891284330 hasConcept C170493617 @default.
• W2891284330 hasConcept C2777389519 @default.
• W2891284330 hasConcept C2778227246 @default.
• W2891284330 hasConcept C502942594 @default.
• W2891284330 hasConcept C54355233 @default.
• W2891284330 hasConcept C62478195 @default.
• W2891284330 hasConcept C7876069 @default.
• W2891284330 hasConcept C81885089 @default.
• W2891284330 hasConcept C86803240 @default.
• W2891284330 hasConcept C95444343 @default.
• W2891284330 hasConceptScore W2891284330C128240485 @default.
• W2891284330 hasConceptScore W2891284330C170493617 @default.

• next